Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors

Hormones and Behavior

Volumn 57, Issue 1, 2010, Pages 12-22

  Finn, Deborah A ^a,b   Beckley, Ethan H ^b   Kaufman, Katherine R ^b   Ford, Matthew M ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adrenalectomy; C57BL 6 mice; Ethanol; Finasteride; Gonadectomy; Handling induced convulsions; Lickometer; Neurosteroid; Reinstatement; Self administration

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ELTANOLONE; FINASTERIDE; NEUROSTEROID; TETRAHYDRODEOXYCORTICOSTERONE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; BEHAVIOR CHANGE; DRINKING BEHAVIOR; DRUG CROSS TOLERANCE; DRUG MECHANISM; DRUG SCREENING; GABAERGIC TRANSMISSION; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEIZURE SUSCEPTIBILITY; SEX DIFFERENCE; WITHDRAWAL SEIZURE;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GABA AGONISTS; MALE; MICE; PREGNANOLONE; RATS; RECEPTORS, GABA-A; REINFORCEMENT (PSYCHOLOGY); SEX CHARACTERISTICS; SEX FACTORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 73049105706     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.07.002     Document Type: Review

References (120)

1. Alele P.E., and Devaud L.L. Sex differences in steroid modulation of ethanol withdrawal in male and female rats. J. Pharmacol. Exp. Ther. 320 (2007) 427-436
2. Almeida O.F.X., Shoaib M., Deicke J., Fischer D., Darwish M.H., and Patchev V.K. Gender differences in ethanol preference and ingestion in rats: the role of the gonadal steroid environment. J. Clin. Invest. 101 (1998) 2677-2685
3. Anton R.F., Drobes D.J., Voronin K., Durazo-Avizu R., and Moak D. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology 173 (2004) 32-40
4. Ballenger J.C., and Post R.M. Kindling as a model for alcohol withdrawal syndromes. Br. J. Psychiatry 133 (1978) 1-14
5. Barbaccia M.L., Affricano D., Trabucchi M., Purdy R.H., Colombo G., Agabio R., and Gessa G.L. Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur. J. Pharmacol. 384 (1999) R1-R2
6. Barbaccia M.L., Serra M., Purdy R.H., and Biggio G. Stress and neuroactive steroids. Int. Rev. Neurobiol. 46 (2001) 243-272
7. Baulieu E.E. Steroid hormones in the brain: several mechanisms. In: Fuxe K., Gustafsson J.A., and Wetterberg L. (Eds). Steroid Hormone Regulation of the Brain (1981), Pergamon, Oxford 3-14
8. Baulieu E.E., Robel P., and Schumacher M. Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46 (2001) 1-32
9. Becker J.B., and Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 29 (2008) 36-47
10. Beckley E.H., Fretwell A.M., Tanchuck M.A., Gililland K.R., Crabbe J.C., and Finn D.A. Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice. Neuropharmacology 54 (2008) 365-374
11. Beekman M., Ungard J.T., Gasior M., Carter R.B., Dijkstra D., Goldberg S.R., and Witkin J.M. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone. J. Pharmacol. Exp. Ther. 284 (1998) 868-877
12. A receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids?. J. Neurosci. 23 (2003) 10013-10020
13. A receptor. Nat. Rev., Neurosci. 6 (2005) 565-575
14. Belelli D., Lan N.C., and Gee K.W. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev. 14 (1990) 315-322
15. Belknap J.K., Crabbe J.C., and Young E.R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112 (1993) 503-510
16. Bevilacqua L., and Goldman D. Genes and addictions. Clin. Pharmacol. Ther. 85 (2009) 359-361
17. Brann D.W., Hendry L.B., and Mahesh V.B. Emerging diversities in the mechanism of action of steroid hormones. J. Steroid Biochem. Mol. Biol. 52 (1995) 113-133
18. Brathen G., Brodtkorb E., Helde G., Sand T., and Bovim G. The diversity of seizures related to alcohol use. A study of consecutive patients. Eur. J. Neurol. 6 (1999) 697-703
19. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk F.Z., and Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 29 (2008) 313-339
20. A receptors. Ann. N.Y. Acad. Sci. 1007 (2003) 29-36
21. Caihol S., and Mormède P. Sex and strain differences in ethanol drinking: effects of gonadectomy. Alcohol. Clin. Exp. Res. 25 (2001) 594-599
22. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., and Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 25 (2004) 273-279
23. A receptor. J. Pharmacol. Exp. Ther. 280 (1997) 1284-1295
24. A receptor modulation of the rewarding and aversive effects of ethanol. Alcohol 26 (2002) 131-143
25. Chester J.A., Barrenha G.D., Hughes M.L., and Keuneke K.J. Age- and sex-dependent effects of footshock stress on subsequent alcohol drinking and acoustic startle behavior in mice selectively bred for high-alcohol preference. Alcohol. Clin. Exp. Res. 32 (2008) 1782-1794
26. Claessens F., Denayer S., Van Tilborgh N., Kerkhofs S., Helsen C., and Haelens A. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl. Recept. Signal. 6 (2008) e008
27. Crabbe J.C. Provisional mapping of quantitative trait loci for chronic ethanol withdrawal severity in BXD Recombinant Inbred mice. J. Pharmacol. Exp. Ther. 286 (1998) 263-271
28. Crabbe J.C., Kosobud A., Young E.R., Tam B.R., and McSwigan J.D. Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav. Genet. 15 (1985) 521-536
29. Crabbe J.C., Young E.R., and Kosobud A. Genetic correlations with ethanol withdrawal severity. Pharmacol. Biochem. Behav. 18 Suppl. 1 (1983) 541-547
30. Crabbe J.C., Phillips T.J., Kosobud A., and Belknap J.K. Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol., Clin. Exp. Res. 14 (1990) 141-151
31. Deshmukh A., Rosenbloom M.J., Sassoon S., O'Reilly A., Pfefferbaum A., and Sullivan E.V. Alcoholic men endorse more DSM-IV withdrawal symptoms than alcoholic women matched in drinking history. J. Stud. Alcohol 64 (2003) 375-379
32. Devaud L.L., and Chadda R. Sex differences in rats in the development of and recovery from ethanol dependence assessed by changes in seizure susceptibility. Alcohol., Clin. Exp. Res. 25 (2001) 1689-1696
33. A receptors to neuroactive steroids in rats during ethanol withdrawal. J. Pharmacol. Exp. Ther. 278 (1996) 510-517
34. A receptors in rats. Brain Res. 796 (1998) 222-230
35. Devaud L.L., Risinger F.O., and Selvage D. Impact of the hormonal milieu on the neurobiology of alcohol dependence and withdrawal. J. Gen. Psychol. 133 (2006) 337-356
36. Eva C., Mele P., Collura D., Nai A., Pisu M.G., Serra M., and Biggio G. Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice. J. Neurochem. 104 (2008) 1043-1054
37. Feunekes G.I., van't Veer P., Van Staveren W.A., and Kok F.J. Alcohol intake assessment: the sober facts. Am. J. Epidemiol. 150 (1999) 105-112
38. Finn D.A., Roberts A.J., Lotrich F., and Gallaher E.J. Genetic differences in behavioral sensitivity to a neuroactive steroid. J. Pharmacol. Exp. Ther. 280 (1997) 820-828
39. Finn D.A., Gallaher E.J., and Crabbe J.C. Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J. Pharmacol. Exp. Ther. 292 (2000) 394-405
40. Finn D.A., Ford M.M., Wiren K.M., Roselli C.E., and Crabbe J.C. The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol. Ther. 101 (2004) 91-112
41. Finn D.A., Sinnott R.S., Ford M.M., Long S.L., Tanchuck M.A., and Phillips T.J. Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice. Neuroscience 123 (2004) 813-819
42. Finn D.A., Long S.L., Tanchuck M.A., and Crabbe J.C. Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol. Biochem. Behav. 78 (2004) 435-443
43. Finn D.A., Beadles-Bohling A.S., Beckley E.H., Ford M.M., Gililland K.R., Gorin-Meyer R.E., and Wiren K.M. A new look at the 5α-reductase inhibitor finasteride. CNS Drug. Rev. 12 (2006) 53-76
44. Finn D.A., Douglass A.D., Beadles-Bohling A.S., Tanchuck M.A., Long S.L., and Crabbe J.C. Selected line difference in sensitivity to a GABAergic neurosteroid during ethanol withdrawal. Genes Brain Behav. 5 (2006) 53-63
45. A receptor gene expression by allopregnanolone and ethanol. Eur. J. Pharmacol. 500 (2004) 413-425
46. Ford M.M., Nickel J.D., and Finn D.A. Treatment with and withdrawal from finasteride alters ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?. Alcohol 37 (2005) 23-33
47. A receptors differentially modulate ethanol intake patterns in male C57BL/6J mice. Alcohol., Clin. Exp. Res. 29 (2005) 1630-1640
48. Ford M.M., Mark G.P., Nickel J.D., Phillips T.J., and Finn D.A. Allopregnanolone influences the consummatory processes that govern ethanol drinking in C57BL/6J mice. Behav. Brain Res. 179 (2007) 265-272
49. Ford M.M., Beckley E.H., Nickel J.D., Eddy S., and Finn D.A. Ethanol intake patterns in female mice: influence of allopregnanolone and the inhibition of its synthesis. Drug Alcohol Depend. 97 (2008) 73-85
50. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13 (2002) 100-105
51. Gasior M., Carter R.B., Goldberg S.R., and Witkin J.M. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J. Pharmacol. Exp. Ther. 282 (1997) 543-553
52. Genazzani A.R., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., Nappi R.E., Luisi S., Palumbo M., Purdy R.H., and Luisi M. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J. Clin. Endocrinol. Metab. 83 (1998) 2099-2103
53. Gililland K.R., and Finn D.A. The impact of gonadectomy and adrenalectomy on acute withdrawal severity in male and female C57BL/6J and DBA/2J mice following a single high dose of ethanol. Alcohol., Clin. Exp. Res. 31 (2007) 1846-1857
54. Goldstein D.B., and Pal N. Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 172 (1971) 288-290
55. Gorin R.E., Crabbe J.C., Tanchuck M.A., Long S.L., and Finn D.A. Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. Alcohol., Clin. Exp. Res. 29 (2005) 939-948
56. Gorin-Meyer R.E., Wiren K.M., Tanchuck M.A., Long S.L., Yoneyama N., and Finn D.A. Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL/6J and DBA/2J mice. Neuroscience 146 (2007) 1302-1315
57. Grant K.A. Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures. Pharmacol. Biochem. Behav. 64 (1999) 261-267
58. A receptors in the acute and chronic effects of ethanol. Psychopharmacology 139 (1998) 2-19
59. Hajszan T., MacLusky N.J., and Leranth C. Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas. Horm. Behav. 53 (2008) 638-646
60. Hashimoto J.G., and Wiren K.M. Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity. Neuropsychopharmacology 33 (2008) 1084-1096
61. Hashimoto J.G., Anacker A.M.J., and Wiren K.M. Selected line differences in the ethanol response: gene expression differences following abstinence in male and female WSP and WSR mice. Alcohol. Clin. Exp. Res 32 s1 (2008) 149A
62. Heilig M., and Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 30 (2007) 399-406
63. Hill M., Popov P., Havlíková H., Lyudmila K., Vrbíková J., Kancheva R., Pouzar V., Černý I., and Stárka L. Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction. Steroids 70 (2005) 515-524
64. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one. Neuropharmacology 43 (2002) 1339-1350
65. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., and Chopde C.T. Evaluation of GABAergic neuroactive steroid 3α-hydroxy-5α-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 180 (2005) 267-278
66. Holdstock L., Penland S.N., Morrow A.L., and de Wit H. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3α-hydroxy-5α-pregnan-20-one-like immunoreactivity in healthy men and women. Psychopharmacology 186 (2006) 442-450
67. Janak P.H., and Gill T.M. Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol 30 (2003) 1-7
68. Janak P.H., Redfern J.E., and Samson H.H. The reinforcing effects of ethanol are altered by the endogenous neurosteroid, allopregnanolone. Alcohol. Clin. Exp. Res. 22 (1998) 1106-1112
69. Kaufman K.R., Tanchuck M.A., Strong M.N., and Finn D.A. Replacement with GABAergic steroids or their precursors alters the acute ethanol withdrawal profile. Alcohol. Clin. Exp. Res. 33 s1 (2009) 156A
70. Kawata M., Nishi M., Matsuda K., Sakamoto H., Kaku N., Masugi-Tokita M., Fujikawa K., Hirahara-Wada Y., Takanami K., and Mori H. Steroid receptor signaling in the brain-lessons learned from molecular imaging. J. Neuroendocrinol. 20 (2008) 673-676
71. Kelly M.J., and Rønnekleiv O.K. Membrane-initiated estrogen signaling in hypothalamic neurons. Mol. Cell. Endocrinol. 290 (2008) 14-23
72. Khisti R.T., VanDoren M.J., Matthews D.B., and Morrow A.L. Ethanol-induced elevation in 3α-hydroxy-5α-pregnan-20-one does not modulate motor incoordination in rats. Alcohol. Clin. Exp. Ther. 28 (2003) 1249-1256
73. Koirala B., Alele P.E., and Devaud L.L. Influence of hormonal status on behavioral responses to an acute ethanol challenge during ethanol withdrawal in male and female rats. Pharmacol. Biochem. Behav. 90 (2008) 691-700
74. A receptors. Prog. Neurobiol. 71 (2003) 67-80
75. Lancaster F.E., Brown T.D., Coker K.L., Elliott J.A., and Wren S.B. Sex differences in alcohol preference and drinking patterns emerge during the early postpubertal period. Alcohol. Clin. Exp. Res. 20 (1996) 1043-1049
76. Le Moal M., and Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur. Neuropsychopharmacology 17 (2007) 377-393
77. Lösel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell. Biol. 4 (2003) 46-56
78. Lynch W.J., Roth M.E., and Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164 (2002) 121-137
79. AR plasticity during pregnancy: relevance to postpartum depression. Neuron 59 (2008) 207-213
80. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nature Neurosci. 8 (2005) 797-804
81. Matsumoto S., Hashimoto K., Yamada M., Satoh T., Hirato J., and Mori M. Liver X receptor-α regulates proopiomelanocortin (POMC) gene transcription in the pituitary. Mol. Endocrinol. 23 (2009) 47-60
82. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12 (1991) 141-147
83. Mellon S.H., and Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13 (2002) 35-43
84. Mellon S.H., and Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46 (2001) 33-78
85. Metten P., and Crabbe J.C. Dependence and withdrawal. In: Deitrich R.A., and Erwin V.G. (Eds). Pharmacological Effects of Ethanol on the Nervous System (1996), CRC Press, New York 269-290
86. A receptor function and gene expression in the central nervous system. Int. Rev. Neurobiol. 38 (1995) 1-41
87. O'Dell L.E., Alomary A.A., Vallee M., Koob G.F., Fitzgerald R.L., and Purdy R.H. Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. Eur. J. Pharmacol. 484 (2004) 241-247
88. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
89. Pierucci-Lagha A., Covault J., Feinn R., Khisti R.T., Morrow A.L., Marx C.E., Shampine L.J., and Kranzler H.R. Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol. Psychopharmacology 186 (2006) 451-461
90. Prediger R.D., daSilva G.E., Batista L.C., Bittencourt A.L., and Takahashi R.N. Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice. Neuropsychopharmacology 10 (2006) 2210-2220
91. Purdy R.H., Morrow A.L., Blinn J.R., and Paul S.M. Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J. Med. Chem. 33 (1990) 1572-1581
92. 35S]GTPγS binding to nociceptin receptors. Neuroendocrinology 88 (2008) 35-42
93. Reddy D.S., and Rogawski M.A. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J. Pharmacol. Exp. Ther. 295 (2000) 1241-1248
94. Roberts A.J., Crabbe J.C., and Keith L.D. Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res. 596 (1992) 296-302
95. Romeo E., Brancati A., De Lorenzo A., Fucci P., Furnari C., Pompili E., Sasso G.F., Spalletta G., Troisi A., and Pasini A. Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin. Neuropharmacology 19 (1996) 366-369
96. Romeo E., Ströhle A., Spalletta G., di Michele F., Hermann B., Holsboer F., Pasini A., and Rupprecht R. Effects of antidepressant treatments on neuroactive steroids in major depression. Am. J. Psychiatry 155 (1998) 910-913
97. Romeo E., Pompili E., di Michele F., Pace M., Rupprecht R., Bernardi G., and Pasinib A. Effects of fluoxetine, indomethacine and placebo on 3alpha, 5alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J. Biol. Psychiatry 1 (2000) 101-104
98. Rupprecht R., and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 22 (1999) 410-416
99. A receptor activity in rat hippocampus. J. Neurosci. 24 (2004) 6521-6530
100. A receptors in the rat hippocampus during pregnancy and after delivery. J. Neurosci. 29 (2009) 1755-1765
101. Sellers E.M. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management. Can. Med. Assoc. J. 139 (1988) 113-120
102. Shen J.-W., Geerling J.C., and Loewy A.D. Vagal innervations of the aldosterone-sensitive HSD2 neurons in the NTS. Brain Res. 1249 (2009) 135-147
103. Sinnott R.S., Phillips T.J., and Finn D.A. Alteration of voluntary ethanol and saccharin consumption by the neurosteroid allopregnanolone in mice. Psychopharmacology 162 (2002) 438-447
104. Spanagel R. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol. Rev. 89 (2009) 649-705
105. Ströhle A., Pasini A., Romeo E., Hermann B., Spalletta G., di Michele F., Holsboer F., and Rupprecht R. Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression. J. Psychiatry Res. 34 (2000) 183-186
106. Tabakoff B., and Hoffman P.L. Alcohol and glutamate receptors. In: Deitrich R.A., and Erwin V.G. (Eds). Pharmacological Effects of Ethanol on the Nervous System (1996), CRC Press, New York 73-93
107. Tanchuck M.A., Long S.L., Ford M.M., Hashimoto J., Crabbe J.C., Roselli C.E., Wiren K.M., and Finn D.A. Selected line differences in the effects of ethanol dependence and withdrawal on allopregnanolone levels and 5α-reductase enzyme activity and expression. Alcohol. Clin. Exp. Res. 33 (2009) 2077-2087
108. Tokuyama Y., Reddy A.P., and Bethea C.L. Neuroprotective actions of ovarian hormones without insult in the raphe regions of rhesus macaques. Neuroscience 154 (2008) 720-731
109. Torres J.M., and Ortega E. Alcohol intoxication increases allopregnanolone levels in female adolescent humans. Neuropsychopharmacology 28 (2003) 1207-1209
110. Torres J.M., and Ortega E. Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology 172 (2004) 352-355
111. Uchoa E.T., Sabino H.A.C., Ruginsk S.G., Antunes-Rodrigues J., and Elias L.L.K. Hypophagia induced by glucocorticoid deficiency is associated with increased activation of satiety-related responses. J. Appl. Physiol. 106 (2009) 596-604
112. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., and Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. 95 (1998) 3239-3244
113. VanDoren M.J., Matthew D.B., Janis G.C., Grobin A.C., Devaud L.L., and Morrow A.L. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J. Neurosci. 20 (2000) 1982-1989
114. Veatch L.M., Wright T.M., and Randall C.L. Only male mice show sensitization of handling-induced convulsions across repeated ethanol withdrawal cycles. Alcohol. Clin. Exp. Res. 31 (2007) 477-485
115. A receptor. Curr. Med. Chem. 16 (2009) 455-472
116. Vengeliene V., Bilbao A., Molander A., and Spanagel R. Neuropharmacology of alcohol addiction. Br. J. Pharmacol. 154 (2008) 299-315
117. Wiren K.M., Hashimoto J.G., Alele P.E., Devaud L.L., Price K.L., Middaugh L.D., Grant K.A., and Finn D.A. Impact of sex: determination of alcohol neuroadaptation and reinforcement. Alcohol. Clin. Exp. Res. 30 (2006) 233-242
118. Wojnar M., Wasilewski D., Matsumoto H., and Cedro A. Differences in the course of alcohol withdrawal in women and men: a Polish sample. Alcohol. Clin. Exp. Res. 21 (1997) 1351-1355
119. Yoneyama N., Crabbe J.C., Ford M.M., Murillo A., and Finn D.A. Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42 (2008) 149-160
120. Young E.A., and Becker J.B. Sex matters: gonadal steroids and the brain. Neuropsychopharmacology 34 (2009) 537-538